These include focused libraries of small-molecule compounds with potential biological activity towards certain diseases (such as Anti-Cancer Compound Library, Anti-Diabetic Compound Library, Anti-Cardiovascular Disease Compound Library, etc.).
Cat No. | product name | ||
---|---|---|---|
L1800 | Anti-Infection Compound Library | A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | 2977 compounds |
L2620 | Anti-Neurodegenerative Disease Compound Library | A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS; | 1622 compounds |
L2191 | Anti-Breast Cancer Compound Library | A unique collection of 1436 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study; | 1436 compounds |
L9840 | Anti-Alzheimer's Disease Compound Library | A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | 1040 compounds |
L2170 | Immuno-Oncology Compound Library | A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; | 454 compounds |
L4710 | Nonsteroidal Anti-Inflammatory Compound Library | 530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. | 530 compounds |
L4700 | Immunology/Inflammation Compound Library | A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening. | 3483 compounds |
L1719 | Nsp15-Targeted Compound Library (CADD) | A unique collection of 470 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 470 compounds |
L4510 | Anti-Parasitic Compound Library | 525 well-chosen unique anti-parasitic small molecules; | 525 compounds |
L2180 | Anti-Cancer Library Plus | Well-chosen 1468 anti-tumor compounds with unique structures; | 1468 compounds |
L1900 | Anti-Diabetic Compound Library | A unique collection of 690 diabetes related compounds; | 690 compounds |
L1715 | Nsp16-Targeted Compound Library (CADD) | A unique collection of 281 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 281 compounds |
L2152 | Targeted Therapy Drug Library | 121 tumor-targeted drugs that can be used for high-throughput and high-content screening. | 121 compounds |
L2192 | Anti-Pancreatic Cancer Compound Library | A unique collection of 1697 pancreatic cancer related compounds can be used in HTS and HCS; | 1697 compounds |
L4660 | Anti-Nervous System Disease Library | Well-chosen 1246 compounds with unique structures targeting nervous system; | 1246 compounds |
L1716 | PLpro-Targeted Compound Library (CADD) | A unique collection of 474 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 474 compounds |
L4520 | Anti-Bacterial Compound Library | A unique collection of 1429 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | 1429 compounds |
L9810 | Anti-Fibrosis Compound Library | A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; | 1180 compounds |
L1714 | RBD-Targeted Compound Library (CADD) | A unique collection of 206 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 206 compounds |
L5400 | Anti-Cardiovascular Disease Compound Library | A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | 1428 compounds |
L2120 | Anti-Cancer Clinical Compound Library | A unique collection of 1990 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | 1990 compounds |
L1710 | Anti-COVID-19 Compound Library | A unique collection of 2446 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; | 2446 compounds |
L2160 | Anti-Cancer Active Compound Library | A unique collection of 2114 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | 2114 compounds |
L2151 | Chemotherapy Drug Library | 51 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. | 51 compounds |
L9830 | Anti-Parkinson's Disease Compound Library | A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | 908 compounds |
L8400 | Hematonosis Compound Library | A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); | 524 compounds |
L2140 | Cancer Cell Differentiation Compound Library | A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening; | 413 compounds |
L7110 | Anti-Hypertension Compound Library | 719 hypertension-related small molecules for high-throughput and high-content screening. | 719 compounds |
L2100 | Anti-Cancer Compound Library | A unique collection of 5885 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | 5885 compounds |
L2150 | Anti-Cancer Drug Library | A unique collection of 2478 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); | 2478 compounds |
L1700 | Anti-Virus Compound Library | A unique collection of 800 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; | 800 compounds |
L1717 | RdRP-Targeted Compound Library (CADD) | A unique collection of 464 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 464 compounds |
L4500 | Anti-Fungal Compound Library | A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. | 253 compounds |
L2110 | Anti-Cancer Approved Drug Library | A unique collection of 1726 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | 1726 compounds |
L7100 | Anti-Obesity Compound Library | A unique collection of 1359 anti-obesity compounds for high throughput and high content screening; | 1359 compounds |
L1711 | Anti-COVID-19 Compound Library (CADD) | A unique collection of 362 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 362 compounds |
L2190 | Anti-Lung Cancer Compound Library | A unique collection of 1566 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study; | 1566 compounds |
L1718 | X Domain-Targeted Compound Library (CADD) | A unique collection of 463 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 463 compounds |
L1712 | 3CLpro-Targeted Compound Library (CADD) | A unique collection of 161 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 161 compounds |
L5200 | Anti-Metabolism Disease Compound Library | A unique collection of 1558 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | 1558 compounds |
L2130 | Anti-Cancer Metabolism Compound Library | A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | 1280 compounds |
L1713 | ACE2-Targeted Compound Library (CADD) | A unique collection of 462 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 462 compounds |